Sensyne Health PLC develops clinically validated software applications powered by artificial intelligence including prescribed digital therapeutics and hospital systems for clinical care. Its products connect patients, clinicians and researchers, generating large databases of phenotypic data, enabling discovery research and improving patient outcomes. The company has developed three clinically validated products (SEND, GDm-Health and EDGE) in collaboration with the University of Oxford and Oxford University Hospitals NHS Foundation Trust and one product.